BrianLeeMcCluneDO
Oncology • Salt Lake City, UTHematologic Oncology
Associate Professor, Medicine, University of Utah
Dr. McClune is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2000 Circle of Hope Drive
RM 4158
Salt Lake City, UT 84112Phone+1 801-587-7000- Is this information wrong?
Education & Training
University of TennesseeFellowship, Hematology and Medical Oncology, 2003 - 2006
Johns Hopkins UniversityResidency, Internal Medicine, 2000 - 2003
Kansas City University of Medicine and Biosciences College of Osteopathic MedicineClass of 2000
Certifications & Licensure
UT State License 2019 - 2024
KS State License 2018 - 2020
MN State License 2006 - 2018
TN State License 2003 - 2011- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Autologous Transplant for Multiple Myeloma Start of enrollment: 2004 Apr 20
- Effectiveness of Etanercept for Idiopathic Pneumonia Syndrome Following Stem Cell Transplantation (BMT CTN 0403) Start of enrollment: 2007 Aug 01
- Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors Start of enrollment: 2006 Dec 19
- Join now to see all
Publications & Presentations
PubMed
- Refractoriness to last line of therapy: how often is it mandated and reported? A systematic review of randomized myeloma trials.Poorva Bindal, Mimi Najjar, Kelly Koehn, Amandeep Godara, Douglas W Sborov, Brian McClune, Kelley Julian, Charlotte Wagner, Ghulam Rehman Mohyuddin> ;Leukemia & Lymphoma. 2023 May 11
- 3 citationsTime-to-event surrogate end-points in multiple myeloma randomised trials from 2005 to 2019: A surrogacy analysis.Tommy Etekal, Kelly Koehn, Douglas W Sborov, Brian McClune, Vinay Prasad, Alyson Haslam, Katherine Berger, Christopher Booth, Samer Al Hadidi, Al-Ola Abdallah, Aaron G...> ;British Journal of Haematology. 2023 Mar 1
- 2 citationsImpact of academic medical center access on outcomes in multiple myeloma.Victoria A Vardell, Daniel A Ermann, Srinivas K Tantravahi, Benjamin Haaland, Brian McClune, Amandeep Godara, Ghulam Rehman Mohyuddin, Douglas W Sborov> ;American Journal of Hematology. 2023 Jan 1
- Join now to see all
Journal Articles
- Caution with Routine Use of Daratumumab for Newly Diagnosed High-Risk Multiple MyelomaBrian McClune, DO, JAMA Oncology
Hospital Affiliations
University of Utah HealthSalt Lake City, Utah
M Health Fairview Southdale HospitalMinneapolis, Minnesota
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
